Company intelligence / Profile preview

Zhejiang Longcharm Biomedical Technology Co., Ltd.

Hangzhou, Zhejiang, Chinanature.com ↗

Ownership: Private
Development stage: Other

Overview

The company has passed FDA remote audits with zero defects for their analysis laboratory and BE project. They have deployed two clinical-stage innovative drugs in oncology.

Therapeutic areas: Oncology
Modalities: Nucleic acid delivery systemsspecial administration routes
Industry: Biotech

Drug pipeline

3 assets

LC301

Preclinical

2 more assets in the full pipeline.

Request access →

Partnerships

Yibai Health (strategic cooperation agreement)universities and enterprises

Beyond the preview

Go deeper on Zhejiang Longcharm Biomedical Technology Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhejiang Longcharm Biomedical Technology Co., Ltd..

Explore the full profile